LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.77 | 771.67 | 4069 | 7256 | 0.5608 | 0.6724 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 53.77 | 771.67 | 4388 | 7256 | 0.6047 | 0.7118 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 6.94 | 771.67 | 1010 | 1045 | 0.9664 | 0.8497 | MN20160304_L01 | I03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 55.99 | 771.67 | 4287 | 7690 | 0.5575 | 0.6770 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 55.99 | 771.67 | 4662 | 7690 | 0.6062 | 0.7199 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | 0 | 42.67 | 771.67 | 5000 | 5155 | 0.9698 | 0.9777 | MN20160304_L01 | D22 | |
| MCF 10A-H2B-mCherry | 0 | 82.69 | 771.67 | 13073 | 11974 | 1.0918 | 1.0449 | MN20160304_L01 | F16 | |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 6.94 | 771.67 | 1191 | 1045 | 1.1396 | 1.6958 | MN20160304_L01 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 771.67 | 4468 | 8085 | 0.5526 | 0.6789 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 58.21 | 771.67 | 4934 | 8085 | 0.6102 | 0.7288 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 9.16 | 771.67 | 1117 | 1138 | 0.9811 | 0.9332 | MN20160304_L01 | I03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.44 | 771.67 | 4676 | 8530 | 0.5481 | 0.6816 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 60.44 | 771.67 | 5218 | 8530 | 0.6117 | 0.7356 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | 0 | 82.69 | 771.67 | 12656 | 11974 | 1.0570 | 1.0282 | MN20160304_L01 | F17 | |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 9.16 | 771.67 | 1302 | 1138 | 1.1436 | 1.5404 | MN20160304_L01 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.66 | 771.67 | 4883 | 8978 | 0.5439 | 0.6839 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 62.66 | 771.67 | 5413 | 8978 | 0.6029 | 0.7336 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 11.56 | 771.67 | 1209 | 1280 | 0.9441 | 0.8485 | MN20160304_L01 | I03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.88 | 771.67 | 5104 | 9447 | 0.5403 | 0.6867 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 64.88 | 771.67 | 5644 | 9447 | 0.5974 | 0.7343 | MN20160304_L01 | M06 |